InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,191.58
(
0.21%
)
US TECH 100
17,653.60
(
0.25%
)
Dow Jones
38,874.27
(
0.06%
)
Brent Oil
83.41
(
-0.08%
)
Bitcoin
63,535.14
(
0.58%
)
Post# of 251743
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 828
Posts 119584
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: TwoNE1 post# 197409

Wednesday, 12/23/2015 10:49:38 AM

Wednesday, December 23, 2015 10:49:38 AM

Post# of 251743
STEM -11% on 25% workforce reduction and termination of AMD program (buried in PR on “strategic realignment”):

http://finance.yahoo.com/news/stemcells-inc-announces-strategic-realignment-130500133.html

“The decision to prioritize our spinal cord injury program required some difficult choices, including the suspension of the Company’s Phase II Radiant Study in geographic atrophy of age-related macular degeneration (GA-AMD) while we seek a partner to fund continued development in retinal disorders,” said StemCells’ CEO Martin McGlynn.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up